Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 77

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 77
---
. The HVII Board also gave consideration to a variety of uncertainties and risks and other potentially negative factors concerning the Business Combination, including, but not limited to, (i) macroeconomic, (ii) regulatory risks, (iii) nuclear risks, (iv) demand risks, (v) no operating history, (vi) commercial contracts risks, (vii) financing risks, (viii) New ONE Nuclear’s public company readiness, (ix) environmental risks, (x) SMR technology risks, (xi) site selection risks, (xii) personnel risks, (xiii) uncertainty of benefits, (xiv) redemption risks, (xv) liquidation of HVII, (xvi) diversion of management attention during the period prior to Closing, (xvii) HVII Shareholder vote, (xviii) non-survival of the representations, warranties or covenants, (xix) satisfaction of the conditions to the Closing, (xx) litigation, (xxi) stock exchange listing risks, (xxii) HVII Shareholders holding a minority ownership in New ONE Nuclear, and (xxiii) significant fees and expenses associated with completing the Business Combination. For a more detailed description of HVII’s reasons for the approval of the Business Combination and the recommendation of the HVII Board, see the section of this proxy statement/prospectus entitled “ The Business Combination — HVII’s Board of Directors’ Reasons for the Approval of the Business Combination.”

| 44 |

Interests of HVII’s Directors and Officers in the Business Combination When considering the HVII Board’s recommendation that HVII Public Shareholders vote in favor of the approval of the Business Combination Proposal, HVII Public Shareholders should be aware that the Sponsor and HVII’s executive officers, and directors have interests in the Business Combination that may be different from or in addition to (and which may conflict with) the interests of HVII Public Shareholders. These interests include:

| ● | the                                                                                                                                                                                                                                                        
 beneficial ownership of the Sponsor and certain members of the HVII Board and officers of an aggregate of (a) 6,333,333 HVII Class B Ordinary Shares, which were acquired for an aggregate purchase price of approximately $25,000 prior to the IPO, which 
 shares would likely be worthless if HVII is unable to effectuate an initial business combination by the end of the Completion Window                                                                                                                       
 and HVII is therefore required to liquidate, as HVII Class B Ordinary Shares are not entitled